About OrSense
OrSense is a Technology company based in Petah Tikva (Israel) founded in 1996. Non-invasive technology for body vitals measurement is developed and commercialized. It operates in the Technology and Healthcare sectors. OrSense has raised $33.2 million across 4 funding rounds from investors including Israel HealthCare Ventures, Star Ventures and ltg-group.com. Its chief executive, as recorded, is Yoav Reisman. OrSense offers products and services including NBM200 and SOLIS. Its focus areas include Semiconductors, Sensors, Generic Sensor Developers and Biological. Its legal entity is OrSense Ltd.
Company details
Founded in 1996 in Petah Tikva, Israel, OrSense operates in the medical device sector, focusing on patient monitoring solutions. Non-invasive continuous measurements of hemoglobin, oxygen saturation, glucose, and other blood parameters are enabled through proprietary Occlusion Spectroscopy technology. Monitoring of SpO2, pulse rate, plethysmogram, and related vitals is supported. Systems are utilized in hospital operating rooms, recovery areas, intensive care units, outpatient facilities, and emergency services.
- Headquarters Petah Tikva, Israel
- SectorsTechnologyHealthcare
- Email••••••••
- Phone•••• ••••
- Website orsense.com
- Social LinkedIn
- Legal Name Orsense Ltd.
- Total Equity Funding$33.2M (USD)
in 4 rounds
- Latest Funding Round$18M (USD), Series B
May 2011
- InvestorsIsrael HealthCare Ventures
& 4 more
Products & Services of OrSense
OrSense offers a comprehensive portfolio of products and services, including NBM200 and SOLIS.
Non-invasive device for measuring hemoglobin and vital signs accurately.
Cloud-based platform for measurements delivery and stock control.
Funding Insights of OrSense
OrSense has successfully raised a total of $33.2M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $18 million completed in May 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $33.2M
- Total Rounds 4
- Last Round Series B — $18M
- First Round $8.2M
(Aug 2001)
- Investors Count 5
All 4 funding rounds of OrSense with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2011 | $18M | Series B | – | ltg-group.com | |
| Dec 2004 | $7M | Series B | – | – | |
| Aug 2001 | $8.2M | Series A | – | Star Ventures, Israel HealthCare Ventures | – |
| Aug 2001 | $1.2M | Grant | – | – |
5 investors in total: 5 institutional.
Investors in OrSense
OrSense has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Israel HealthCare Ventures, Star Ventures and ltg-group.com.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| ihcv.co.il | ||||
Early & late stage sector-agnostic VC firm investing in the US, Asia and Middle East | star-ventures.com | Herzliya, Israel | ||
| tamarventures.com | ||||
| ltg-group.com | ||||
| moital.gov.il |
Investor details for OrSense
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of OrSense
10 people are tracked at OrSense (4 in leadership, 6 in team).
| Name | Role | Group |
|---|---|---|
Yoav Reisman | CEO | Leadership |
Chip Neff | President | Leadership |
Efi Gabis | Vice President Operations | Leadership |
Guy Greitser | VP Business Development | Leadership |
Amanda Johnson | U.s. Business Operations Manager | Team |
Ilya Lipovsky | Optical Laboratory Manager | Team |
Shahar Vaknin | Production Manager | Team |
Ravit Tsigel Fishbine | Purchasing & Production Planning Control | Team |
Eduardo Burger | International Sales Manager | Team |
Amit Har-Noy | Process Engineer And MRB Lead | Team |
Complete people profiles for OrSense
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of OrSense
3 dated milestones of OrSense across 15 years, from founding to its latest funding, stage changes and deals.
- Founded OrSense is founded.
- Funding First funding round of $8.2M.
- Funding Latest funding round, Series B, of $18.0M.
Web traffic of OrSense
The website of OrSense (orsense.com) receives about 2K visits a month.
- Monthly visits2K
▲ 10% vs previous month
Websites whose visitors overlap most with OrSense. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| mgcdiagnostics.com | 100% | 9.5K | #2,396,104 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Orsense
Complete news archive for OrSense
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about OrSense
OrSense was founded in 1996 and raised its 1st funding round 5 years after it was founded.
OrSense is headquartered in Petah Tikva, Israel. It is registered at Petah Tikva, Central District, Israel.
Yoav Reisman is the CEO of OrSense, as recorded in our data.
OrSense is a funded company, having raised a total of $33.2M across 4 funding rounds to date. The company's 1st funding round was a Series A of $8.2M, raised on Aug 2001.
Founded in 1996 in Petah Tikva, Israel, OrSense operates in the medical device sector, focusing on patient monitoring solutions. Non-invasive continuous measurements of hemoglobin, oxygen saturation, glucose, and other blood parameters are enabled through proprietary Occlusion Spectroscopy technology. Monitoring of SpO2, pulse rate, plethysmogram, and related vitals is supported. Systems are utilized in hospital operating rooms, recovery areas, intensive care units, outpatient facilities, and emergency services.
OrSense offers NBM200 and SOLIS.
OrSense has 5 investors. Key investors include Israel HealthCare Ventures, Star Ventures, ltg-group.com, Tamar Ventures, and moital.
OrSense operates through Orsense Ltd..